ArticleFrontiers in medicine2026
Landmark-based early perfusion phenotyping for prognostic stratification in septic shock: derivation in MIMIC-IV and fixed-parameter external transportability assessment in eICU.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Septic shock is clinically heterogeneous, and early perfusion failure may not be adequately captured by any single bedside variable. We aimed to derive a clinically interpretable early perfusion phenotyping framework within a landmark design and assess whether the high-risk phenotype contour could be transferred across critical care databases. Methods: In this retrospective observational study, MIMIC-IV was used for phenotype derivation and the eICU Collaborative Research Database for fixed-parameter external transportability assessment. Adults in the first intensive care unit stay were eligible if they had early vasopressor exposure and baseline lactate greater than 2 mmol/L. At an 8-h landmark, phenotypes were derived using mean arterial pressure deficit burden, body-weight-standardized urine output, and lactate clearance. The primary outcome was in-hospital mortality, selected for cross-database harmonization because it was consistently available in both databases, whereas fixed-time 28- or 90-day mortality was not reliably harmonized. Secondary renal outcomes were summarized descriptively. Results: The MIMIC landmark cohort included 4,374 patients, of whom 2,671 had complete data for phenotype assignment. Four early perfusion phenotypes were identified. Phenotype 1 was characterized by greater hypotensive burden, poorer lactate clearance, and lower urine output. In-hospital mortality was 47.0% in Phenotype 1 versus 17.7% in Phenotype 4. Phenotype 1 remained associated with higher mortality after primary adjustment for age, sex, and pre-landmark SOFA score (OR 3.67, 95% CI 2.74-4.93), but this estimate attenuated after expanded pre-landmark case-mix adjustment (OR 2.56, 95% CI 1.85-3.53). In eICU, the same high-risk contour remained detectable under frozen transfer among measured complete-case patients. However, the strict and relaxed transfer cohorts were small, monitoring-dense subsets, and class-prevalence drift with measurement-dependent complete-case formation precluded robust conclusions about transportability of the entire four-class model, particularly for Phenotypes 2-4. Conclusions: A landmark-based early perfusion phenotype identified a high-risk perfusion-failure contour among septic shock patients with sufficient early monitoring density. In eICU, this contour was recoverable only within measured complete-case subsets, and the external data do not establish robust transportability of the entire four-class model. The framework should be interpreted as an observational, hypothesis-generating prognostic stratification approach rather than as an independently validated bedside decision tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.